ING gives update on climate action approach, accelerates efforts in client engagement ING gives update on climate action approach, accelerates efforts in client engagement ING today published its annual Climate Progress Update. The update shows how we engage with our clients to help them in the transition to a low-carbon economy. It also includes our progress on steering the most carbon-intensive sectors in our loan portfolio towards global climate goals – our ‘Terra’ approach. As a bank, the most impactful way for us to contribute to the transition is through financing: working with clien...
NEW YORK--(BUSINESS WIRE)-- Medidata, une marque de Dassault Systèmes et principal fournisseur de solutions d'essais cliniques pour l'industrie des sciences du vivant, a été qualifié de leader dans la toute première évaluation PEAK Matrix® d'Everest Group pour la saisie électronique des données (EDC) en matière de sciences du vivant. Le rapport, qui a évalué 20 fournisseurs, a mis en exergue de Medidata en raison de son intégration sans heurt avec les wearables, les capteurs et les EHR, ainsi que de ses fonctionnalités avancées en matière de vérification des données sources, de sa gestion de...
NEW YORK--(BUSINESS WIRE)-- Medidata, a Dassault Systèmes brand and the leading provider of clinical trial solutions to the life sciences industry, has been recognized as a Leader in Everest Group‘s first-ever PEAK Matrix® Assessment for Electronic Data Capture (EDC) in life sciences. The report, which evaluated 20 providers, highlighted Medidata for its seamless integration with wearables, sensors, and EHRs, along with its advanced capabilities in source data verification, AI-driven query management, and adverse event handling. Rave EDC earned recognition for its intuitive, low-code design,...
Progress on share buyback programme Progress on share buyback programme ING announced today that, as part of our €2.5 billion share buyback programme announced on 2 May 2024, the company repurchased 3,282,664 shares during the week of 9 September 2024 up to and including 13 September 2024. The shares were repurchased at an average price of €16.20 for a total amount of €53,166,251.32. For detailed information on the daily repurchased shares, individual share purchase transactions and weekly reports, see the ING website at . In line with the purpose of the programme to reduce the share ca...
LONDRES--(BUSINESS WIRE)-- , marque de Dassault Systèmes et principal fournisseur de solutions d’essais cliniques pour l’industrie des sciences de la vie, et l'Organisation européenne pour la recherche et le traitement du cancer (EORTC), annoncent aujourd'hui une prolongation de quatre ans de leur partenariat. La relation étendue permettra à l'EORTC d'accroître encore l'accès des patients aux essais cliniques en oncologie, de faciliter la participation aux essais et d'aider à mettre plus rapidement de nouveaux traitements sur le marché. L'EORTC exploite actuellement 13 solutions Medidata, perm...
LONDON--(BUSINESS WIRE)-- , a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, and the European Organisation for Research and Treatment of Cancer (EORTC), announced today a four-year extension to their partnership. The extended relationship will enable EORTC to further increase patient access to oncology clinical trials, make trial participation easier, and help to deliver new treatments to the market faster. EORTC is now leveraging 13 Medidata solutions, enabling their researchers to access and manage all clinical data in a single place a...
1M Performance - Absolute: During July'24 (1M period), the KBCS Holdings Universe posted a return of 0.5% which was mainly driven by multi-asset holdings (+1.7%) while single-asset holdings posted a negative return of -1.3%. The 3 top performers during the period were HAL Trust (+5.1%), Texaf (+2.9%), and The Infrastructure Company (TINC, +9.6%) while the 3 worst performers were Brederode (-2.8%), Solvac (-5.3%), and Whitestone Group (-7.2%). YTD Performance - Relative: On a YTD basis (as of A...
Progress on share buyback programme Progress on share buyback programme ING announced today that, as part of our €2.5 billion share buyback programme announced on 2 May 2024, the company repurchased 3,625,795 shares during the week of 2 September 2024 up to and including 6 September 2024. The shares were repurchased at an average price of €16.24 for a total amount of €58,886,036.06. For detailed information on the daily repurchased shares, individual share purchase transactions and weekly reports, see the ING website at . In line with the purpose of the programme to reduce the share cap...
Although share price gains in the European banking sector have been significant in recent quarters, comfortably outperforming the general market; valuation multiples have lagged behind. The European banking sector has become cheaper relative to the market, and in absolute terms are still a low levels historically. Despite declining interest rates, the fundamental environment remains benign, providing a solid entry point for investors. In this note we specifically look at ABN Amro & ING. Revised ...
We host the 15th edition of the Corporate Conference in cooperation with Commerzbank on September 3rd & 4th 2024 in Frankfurt am Main. This year we are welcoming 90 German small, mid and large cap companies. - >Accelor Mittal (=) – Heading for better H2 despite still soft underlying markets, no change on VallourecAdesso (=) – IT-solutions segment will continue to be a drag on profitability in H2 2024Aurubis (+) – Announced disposal for its US-based finished ...
LONDRES--(BUSINESS WIRE)-- , marque de Dassault Systèmes et principal fournisseur de solutions d’essais cliniques pour l’industrie des sciences de la vie, a annoncé aujourd’hui un nouveau projet avec Aixial Group, un organisme de recherche sous contrat (CRO), visant à harmoniser l’exécution des études et d’accélérer le verrouillage de la base de données. Aixial Group migrera les données cliniques de l’une de ses unités commerciales sur la afin de créer une source unique de vérité (SSOT) qui permettra aux équipes d’étude de respecter la confidentialité des données des patients, d’assurer un su...
LONDON--(BUSINESS WIRE)-- , a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced a new project with Aixial Group, a contract research organization (CRO), to streamline the execution of studies and achieve database lock faster. Aixial Group will migrate clinical data from one of its business units onto the to create a Single Source of Truth (SSOT) that enables study teams to support patient data privacy, monitor throughout the study to keep patients safe, and make better-informed decisions. "Aixial Group offers our trial sp...
Progress on share buyback programme Progress on share buyback programme ING announced today that, as part of our €2.5 billion share buyback programme announced on 2 May 2024, the company repurchased 3,268,026 shares during the week of 26 August 2024 up to and including 30 August 2024. The shares were repurchased at an average price of €16.21 for a total amount of €52,962,194.42. For detailed information on the daily repurchased shares, individual share purchase transactions and weekly reports, see the ING website at . In line with the purpose of the programme to reduce the share capital...
>Strong earnings improvement in unquoted companies - Net earnings H1: € 5.65 per share. HAL reports 24H1 earnings of € 510m (€ 5.65 per share) , which is down 7% from the € 550m (€ 6.09 per share) reported in 23H1. Net income from the quoted interests in 24H1 amounted to € 144m, slightly up from € 140m in 23H1. /Market NAV: € 163.7 per share. On 30 June, the market NAV amounted to € 14,474m (€ 160.17 per share), up 6.7% from € 13,563m (€ 150.12 per share) at...
At end-1H FY24, NAVps was at €160.2 (€14,474m), up 6.7% vs. €150.1 during FY23-end. HAL Trust has agreed to sell its entire stake in Pro Gamers Group, an asset with little to no value due to impairments. On the other hand, the group increased its stake in Coolblue to 56.4% by investing €25.0m for an additional 7.5% (implied equity value = €333m vs. €340m KBCSe). Boskalis' posted a robust set of 1H results with revenue rising 5% to €2.1b, EBITDA rising 50.0% to 0.55m and net profit rising 65% to ...
Progress on share buyback programme Progress on share buyback programme ING announced today that, as part of our €2.5 billion share buyback programme announced on 2 May 2024, the company repurchased 11,078,000 shares during the week of 19 August 2024 up to and including 23 August 2024. The shares were repurchased at an average price of €15.85 for a total amount of €175,559,516.60. For detailed information on the daily repurchased shares, individual share purchase transactions and weekly reports, see the ING website at . In line with the purpose of the programme to reduce the share capit...
>Conclusion: Pro forma Solvency and excess capital better, operationally in line - End 1H24 the pro forma group Solvency 2 ratio was with 196% higher than expected as a result of more benefits from the Knab Aegon bank sale. As a result the excess capital is about € 300m higher which is positive for the for excess capital adjusted FCF yield, which is about 14%. We have a good S2 ratio of 212% for end 2025. In 1H24 the non-life life result was good with above market ave...
ASR: 1H small beat, KNAB add-on to Solvency 2 higher. Avantium: Down to the wire. Flow Traders: Pump up the volume. Greenyard: 1Q24/25 preview. Kendrion: Navigating difficult end markets. Montea: Solid results with no surprises, guidance reiterated. NEPI Rockcastle: Guidance raised, M&A opportunities on the radar. Tessenderlo: 1H24 Adj. EBITDA miss of 5%, lower FY guidance
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.